Delivery Order SPE2DB24D3013-SPE2DB24FFGBM
Award Date
7/3/24
Potential Completion Date
7/5/24
Potential Value
$17K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $100,378.46, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DUPIXENT 300 MG/2 ML PEN 2ML, a medical product, with an ultimate completion date of January 7, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop...
This federal contract award, valued at $36,793.31, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of DUPIXENT 300 MG/2 ML PEN 2ML, with an ultimate completion date of January 13, 2025. The contract is a firm-fixed-price agreement with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite...
This federal contract award, worth $16,653.21, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DUPIXENT 300 MG/2 ML PEN 2ML, a specialty pharmaceutical product. The contract has a period of performance through July 3, 2024 and is a firm fixed-price delivery order. Amerisourcebergen Drug Corp is the prime contractor, and the contract was not set aside for...
This federal contract award, valued at $14,172.90, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of DUPIXENT 300 MG/2 ML PEN 2ML, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of November 13, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a significant...
This federal contract award, valued at $16,511.30, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of DUPIXENT 300 MG/2 ML PEN 2ML, a pharmaceutical product. The contract has an ultimate completion date of February 7, 2025 and is a Firm Fixed Price arrangement. This award is associated with a larger Indefinite Delivery Contract (IDC) between...
This federal contract award, valued at $18,410.41, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DUPIXENT 300 MG/2 ML PEN 2ML, a pharmaceutical product, with an ultimate completion date of January 3, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. Amerisourcebergen Drug Corp is the prime contractor, and there is no...
This federal contract award, valued at $10,860.74, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DUPIXENT 300 MG/2 ML PEN 2ML, a medical product, with a completion date of March 10, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type and does not have a set-aside designation. Amerisourcebergen Drug Corp holds a significant Indefinite...
This federal contract award, valued at $16,873.49, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm Fixed Price Delivery Order with a completion date of December 30, 2024. It covers the supply of DUPIXENT 300 MG/2 ML PEN 2ML, a pharmaceutical product, to support military healthcare programs. This contract is part of a larger Indefinite Delivery Contract (IDC) that...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $16,923.91, is a Delivery Order for the supply of DUPIXENT 300 MG/2 ML PEN 2ML medical product. The contract has an ultimate completion date of January 8, 2025 and is a Firm Fixed Price arrangement. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,445.88 firm fixed-price delivery order is for the supply of DUPIXENT 300 MG/2 ML PEN 2ML, a pharmaceutical product. The contract has an ultimate completion date of February 3, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...